Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
09/23/2020 09/24/2020 09/25/2020 09/28/2020 09/29/2020 Date
71.72(c) 71.3(c) 71.52(c) 72.3(c) 72.4(c) Last
552 362 423 359 335 190 384 193 302 733 Volume
+0.87% -0.59% +0.31% +1.09% +0.14% Change
More quotes
Financials (USD)
Sales 2020 21 540 M - -
Net income 2020 1 538 M - -
Net Debt 2020 14 778 M - -
P/E ratio 2020 16,1x
Yield 2020 1,65%
Sales 2021 22 564 M - -
Net income 2021 1 700 M - -
Net Debt 2021 13 750 M - -
P/E ratio 2021 14,5x
Yield 2021 1,76%
Capitalization 24 722 M 24 674 M -
EV / Sales 2020 1,83x
EV / Sales 2021 1,71x
Nbr of Employees 124 736
Free-Float 65,0%
More Financials
Company
Fresenius Medical Care AG & Co. KGaA is the world's leading supplier of services and equipment for patients with kidney problems. Net sales break down by activity as follows: - clinical care services (79.4%): operated, at the end of 2019, 3,994 institutions; - manufacturing of dialyzers and related products (20.6%): hemo-dialysis and pediatric dialysis machines, etc. The group also offers therapies accompanied by... 
More about the company
Notations Surperformance© of Fresenius Medical Care AG & Co. KGaA
Trading Rating : Investor Rating :
More Ratings
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
09/25FRESENIUS MEDICAL CARE : The Power of Ideas and the people behind them, Freseniu..
AQ
09/23FRESENIUS SE : Buy rating from Goldman Sachs
MD
09/23FMC FRESENIUS MEDICAL CARE AG & CO K : Barclays reiterates its Buy rating
MD
09/23FRESENIUS SE : Receives a Buy rating from Berenberg
MD
09/23FRESENIUS SE : Barclays takes a positive view
MD
09/21FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Buy rating from Goldman Sachs
MD
09/17FMC FRESENIUS MEDICAL CARE AG & CO K : Receives a Buy rating from JP Morgan
MD
09/16FRESENIUS MEDICAL CARE : Essential Role of Ultrapure Dialysis Fluid Highlighted ..
BU
09/10FRESENIUS MEDICAL CARE : to issue bonds with a volume of 1 billion US-dollars
PU
09/03FMC FRESENIUS MEDICAL CARE AG & CO K : JP Morgan gives a Buy rating
MD
09/03FRESENIUS SE : JP Morgan gives a Buy rating
MD
09/02BBVA, Societe Generale Move out of Europe's Leading Blue-Chip Index
DJ
09/02Tech sector tightens its grip over Europe's stock markets
RE
09/01FRESENIUS SE : Morgan Stanley reaffirms its Buy rating
MD
08/28FRESENIUS MEDICAL CARE : Strong growth despite the pandemic, Annual General Meet..
AQ
More news
News in other languages on FRESENIUS MEDICAL CARE AG & CO. KGAA
09/28Nestlé mise sur les jeunes pousses pour conquérir le créneau végétarien
09/24DIE MACHT DER IDEEN UND DIE MENSCHEN : Fresenius Medical Care veröffentlicht Med..
09/23FRESENIUS : soutenu par un relèvement de broker
09/23FRESENIUS SE : Goldman Sachs optimiste sur le dossier
09/23Goldman belässt Fresenius SE auf 'Buy' - Ziel 47 Euro
More news
Analyst Recommendations on FRESENIUS MEDICAL CARE AG & CO. KGAA
More recommendations
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 98,21 $
Last Close Price 84,43 $
Spread / Highest target 39,1%
Spread / Average Target 16,3%
Spread / Lowest Target -10,0%
EPS Revisions
Managers
NameTitle
Rice Powell Chairman-Management Board
Dieter Schenk Chairman-Supervisory Board
Helen Giza Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer